Chapter 2
The Human Brain and Nervous System
To understand Parkinson’s disease, it is first necessary to understand the remarkable organ it affects—the human brain. The brain is often described as the body’s command center, controlling everything from breathing and heartbeat to memory, emotions, movement, and decision-making. Although it weighs only about 1.3 to 1.5 kilograms (approximately three pounds), the brain contains an astonishing network of roughly 86 billion nerve cells, called neurons, connected by trillions of communication points known as synapses. Together, these cells create one of the most complex biological systems in nature.
The nervous system is divided into two major parts: the central nervous system and the peripheral nervous system. The central nervous system consists of the brain and spinal cord. It receives information from the body, processes that information, and sends instructions back to muscles and organs. The peripheral nervous system includes all the nerves that extend from the brain and spinal cord to the rest of the body. These nerves carry sensory information, such as touch, temperature, and pain, back to the brain while also delivering commands that allow muscles to move.
Every movement we make begins in the brain. Something as simple as lifting a cup of coffee involves an intricate sequence of events. The brain decides to perform the action, calculates the amount of force required, coordinates the muscles involved, maintains balance, adjusts posture, and monitors the movement as it occurs. All of these tasks happen within fractions of a second, usually without conscious thought. The smoothness and precision of our movements depend on healthy communication among different regions of the brain.
Neurons are the building blocks of this communication system. Each neuron consists of a cell body, branching structures called dendrites that receive signals, and a long projection known as an axon that sends electrical impulses to other neurons. Electrical signals travel rapidly through these cells, but communication between neurons occurs through chemicals called neurotransmitters. These neurotransmitters cross tiny gaps called synapses, carrying messages from one neuron to the next. Without neurotransmitters, the brain would be unable to coordinate even the simplest physical or mental activity.
Among the many neurotransmitters in the human brain, dopamine plays a particularly important role in movement. Dopamine is often referred to as the “movement neurotransmitter,” although its functions extend far beyond muscle control. It also influences motivation, learning, reward, mood, attention, and decision-making. In Parkinson’s disease, it is the movement-related functions of dopamine that are most profoundly affected.
Dopamine is produced primarily by specialized neurons located in a small area of the brain called the substantia nigra, a Latin term meaning “black substance.” This structure lies within the midbrain and appears dark because its cells contain a pigment called neuromelanin. Although the substantia nigra occupies only a tiny portion of the brain, it has an enormous influence on the body’s ability to move efficiently. The dopamine-producing neurons in this region send their long axons to another important brain structure known as the striatum, forming a communication pathway called the nigrostriatal pathway.
The nigrostriatal pathway acts like a sophisticated control system for movement. Rather than directly causing muscles to contract, it fine-tunes the signals generated by other motor centers. It helps determine how fast movements should occur, how forceful they should be, and how smoothly different muscles work together. When dopamine levels are normal, movements are fluid, coordinated, and automatic. When dopamine becomes deficient, movement becomes slower, stiffer, and more difficult to initiate.
The basal ganglia are another essential component of this system. The basal ganglia are a group of interconnected structures located deep within the brain. These structures include the caudate nucleus, putamen, globus pallidus, subthalamic nucleus, and substantia nigra. Together, they regulate voluntary movement, posture, muscle tone, and motor learning. They also contribute to habits, emotional processing, and certain aspects of thinking.
One useful way to understand the basal ganglia is to imagine an orchestra. The cerebral cortex, the outer layer of the brain, writes the musical score by planning movements. The muscles serve as the musicians who perform the music. The basal ganglia function as the conductor, ensuring that every section plays at the correct time, speed, and intensity. Dopamine allows the conductor to communicate clearly with every musician. When dopamine levels fall, coordination deteriorates, timing becomes inconsistent, and movements lose their natural rhythm.
The brain also relies on another important structure called the cerebellum. While the basal ganglia regulate the initiation and smooth execution of movement, the cerebellum coordinates balance, precision, posture, and fine motor control. It constantly receives information from the muscles, joints, inner ear, and eyes, making rapid adjustments to ensure stability. When walking across uneven ground, climbing stairs, or catching a ball, the cerebellum performs countless calculations every second without conscious effort.
Communication within the nervous system depends not only on dopamine but also on numerous other neurotransmitters. Acetylcholine contributes to learning, memory, and muscle activation. Serotonin influences mood, sleep, and emotional well-being. Norepinephrine regulates attention, alertness, and blood pressure. Glutamate serves as the primary excitatory neurotransmitter, while gamma-aminobutyric acid (GABA) acts as the principal inhibitory neurotransmitter, preventing excessive nerve activity. A healthy brain depends on a careful balance among all these chemical messengers.
Parkinson’s disease disrupts this delicate balance. As dopamine-producing neurons gradually die, other neurotransmitter systems attempt to compensate for the loss. Initially, the brain adapts remarkably well, explaining why symptoms may not appear until approximately 50 to 70 percent of dopamine-producing neurons have already been lost. During this early phase, the remaining healthy neurons increase their dopamine production, temporarily masking the disease. Eventually, however, compensation becomes insufficient, and the characteristic symptoms begin to emerge.
The process of voluntary movement begins in the motor cortex, located in the frontal lobe of the brain. The motor cortex develops a movement plan and sends signals to the basal ganglia. The basal ganglia evaluate the movement, refine it, and return modified signals through the thalamus back to the motor cortex. The motor cortex then sends instructions down the spinal cord, where motor neurons activate individual muscles. Dopamine is essential at multiple stages of this feedback loop, ensuring that movements start promptly, proceed smoothly, and stop appropriately.
When dopamine levels decline in Parkinson’s disease, this motor circuit becomes less efficient. Initiating movement requires greater effort, resulting in bradykinesia, or slowness of movement. Muscles may remain continuously active, producing rigidity. Resting tremors arise because of abnormal signaling within motor circuits, although researchers continue to investigate the exact mechanisms responsible. Balance becomes increasingly difficult because the brain struggles to coordinate posture and muscle responses effectively.
Interestingly, Parkinson’s disease affects much more than movement. Dopamine pathways extend into regions involved in emotion, motivation, and cognition. Other neurotransmitter systems, including serotonin and norepinephrine, are also affected as the disease progresses. This explains why many individuals experience depression, anxiety, fatigue, sleep disturbances, constipation, reduced sense of smell, and cognitive changes long before significant motor symptoms appear. These non-motor symptoms are now recognized as integral features of Parkinson’s disease rather than secondary complications.
Another important concept is neuroplasticity, the brain’s remarkable ability to adapt and reorganize itself. Even after injury or disease, healthy neurons can form new connections, strengthen existing pathways, and sometimes assume functions previously performed by damaged cells. Neuroplasticity forms the scientific basis for many rehabilitation strategies used in Parkinson’s disease. Regular exercise, physical therapy, occupational therapy, speech therapy, cognitive training, and engaging in mentally stimulating activities encourage the brain to develop alternative neural pathways that improve function and maintain independence.
Exercise is especially powerful because it stimulates the release of growth factors that support neuronal health. Studies have shown that aerobic exercise, resistance training, balance exercises, dancing, tai chi, cycling, and treadmill walking can improve mobility, reduce stiffness, enhance balance, and improve quality of life. Although exercise does not replace dopamine-producing neurons, it helps the nervous system function more efficiently and supports overall brain health.
Sleep also plays a vital role in maintaining the nervous system. During sleep, the brain consolidates memories, clears metabolic waste products, repairs cellular damage, and restores energy reserves. Poor sleep quality may worsen concentration, mood, and movement symptoms in people with Parkinson’s disease. Establishing healthy sleep habits therefore becomes an important component of comprehensive care.
Nutrition influences brain function as well. The brain requires a continuous supply of oxygen, glucose, healthy fats, vitamins, minerals, and antioxidants to function optimally. Diets rich in fruits, vegetables, whole grains, legumes, nuts, fish, and healthy oils support cardiovascular health, which in turn benefits brain circulation. Adequate hydration, fiber intake, and balanced nutrition also help manage several non-motor symptoms commonly associated with Parkinson’s disease, including constipation and fatigue.
Modern technology has dramatically improved scientists’ understanding of the nervous system. Advanced imaging techniques such as magnetic resonance imaging (MRI), positron emission tomography (PET), and dopamine transporter (DaT) scans allow researchers to study brain structure and function in unprecedented detail. Wearable sensors, smartphone applications, and artificial intelligence systems are increasingly being used to monitor movement patterns, detect early symptom changes, and personalize treatment strategies.
Research has also revealed that Parkinson’s disease may begin years before noticeable movement symptoms appear. Scientists believe abnormal clumps of a protein called alpha-synuclein may accumulate in nerve cells long before significant dopamine loss occurs. Some researchers propose that these abnormal proteins may initially develop in the digestive tract or olfactory system before spreading to the brain through interconnected neural pathways. Although this theory continues to be investigated, it has expanded scientific understanding of the disease and opened new avenues for early diagnosis and treatment.
The complexity of the human brain explains why Parkinson’s disease presents differently in every individual. Because multiple brain regions and neurotransmitter systems are involved, symptoms vary widely in severity, progression, and response to treatment. Some people experience prominent tremors, while others primarily struggle with stiffness or balance problems. Some develop cognitive changes relatively early, whereas others maintain normal thinking abilities for decades. This diversity highlights the importance of individualized treatment plans tailored to each person’s unique needs.
Understanding the brain and nervous system provides the foundation for understanding Parkinson’s disease itself. Rather than viewing the condition simply as a disease that causes shaking, it becomes clear that Parkinson’s is a disorder affecting an intricate communication network responsible for movement, emotion, sleep, thinking, and many automatic body functions. Appreciating this complexity allows patients, families, and healthcare professionals to approach treatment from a comprehensive perspective that addresses the whole person rather than only the visible symptoms.
As neuroscience continues to advance, researchers are uncovering new details about how neurons communicate, why dopamine-producing cells become vulnerable, and how future therapies might protect or restore damaged brain circuits. These discoveries offer hope that tomorrow’s treatments may not only relieve symptoms but also slow or prevent disease progression. The remarkable resilience of the human brain, combined with ongoing scientific innovation, remains one of the greatest reasons for optimism in the fight against Parkinson’s disease.
In the next chapter, we will examine the underlying causes of Parkinson’s disease in greater detail, exploring why dopamine-producing neurons die, the role of alpha-synuclein and Lewy bodies, genetic influences, environmental risk factors, and the latest scientific theories explaining the development of this complex neurological disorder.
